Ann Wiegand

3.6k total citations
18 papers, 2.2k citations indexed

About

Ann Wiegand is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Ann Wiegand has authored 18 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Virology and 2 papers in Immunology. Recurrent topics in Ann Wiegand's work include HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (16 papers) and HIV/AIDS drug development and treatment (16 papers). Ann Wiegand is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (16 papers) and HIV/AIDS drug development and treatment (16 papers). Ann Wiegand collaborates with scholars based in United States, Sweden and Denmark. Ann Wiegand's co-authors include John M. Coffin, Sarah Palmer, John W. Mellors, David M. Margolis, Ronald J. Bosch, Frank Maldarelli, Joseph J. Eron, JoAnn M. Mican, Julia A. Metcalf and Michael A. Polis and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Virology.

In The Last Decade

Ann Wiegand

18 papers receiving 2.2k citations

Peers

Ann Wiegand
S. Alireza Rabi United States
Delphine Engel United States
Geethanjali Dornadula United States
Anne Ellett Australia
Jun Lai United States
Maarten Koot Netherlands
Megan Mefford United States
Åsa Björndal Sweden
Silvia Ratto‐Kim United States
Ronald J. Plishka United States
S. Alireza Rabi United States
Ann Wiegand
Citations per year, relative to Ann Wiegand Ann Wiegand (= 1×) peers S. Alireza Rabi

Countries citing papers authored by Ann Wiegand

Since Specialization
Citations

This map shows the geographic impact of Ann Wiegand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Wiegand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Wiegand more than expected).

Fields of papers citing papers by Ann Wiegand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Wiegand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Wiegand. The network helps show where Ann Wiegand may publish in the future.

Co-authorship network of co-authors of Ann Wiegand

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Wiegand. A scholar is included among the top collaborators of Ann Wiegand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Wiegand. Ann Wiegand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lackman-Smith, Carol, Sonia Bakkour, Ann Wiegand, et al.. (2023). Application of ultrasensitive digital ELISA for p24 enables improved evaluation of HIV-1 reservoir diversity and growth kinetics in viral outgrowth assays. Scientific Reports. 13(1). 10958–10958. 5 indexed citations
2.
Wonderlich, Elizabeth R., Bryan D. Cox, Ann Wiegand, et al.. (2019). Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals. PLoS Pathogens. 15(10). e1008074–e1008074. 29 indexed citations
3.
Wiegand, Ann & Frank Maldarelli. (2013). Single-Copy Quantification of HIV-1 in Clinical Samples. Methods in molecular biology. 1087. 251–260. 4 indexed citations
4.
Kearney, Mary F., Jonathan Spindler, Ann Wiegand, et al.. (2012). Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection. PLoS ONE. 7(2). e30889–e30889. 33 indexed citations
5.
Mens, Helene, Mary F. Kearney, Ann Wiegand, et al.. (2011). Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays. Journal of Visualized Experiments. 10 indexed citations
6.
Gandhi, Rajesh T., Robert W. Coombs, Ellen S. Chan, et al.. (2011). No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(3). 229–235. 89 indexed citations
7.
8.
9.
Mens, Helene, Mary F. Kearney, Ann Wiegand, et al.. (2011). Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays. Journal of Visualized Experiments. 1 indexed citations
10.
Gandhi, Rajesh T., Lu Zheng, Ronald J. Bosch, et al.. (2010). The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial. PLoS Medicine. 7(8). e1000321–e1000321. 242 indexed citations
11.
Halvas, Elias K., Ann Wiegand, Valerie F. Boltz, et al.. (2010). Low Frequency Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant Variants Contribute to Failure of Efavirenz‐Containing Regimens in Treatment‐Experienced Patients. The Journal of Infectious Diseases. 201(5). 1818331743–0. 81 indexed citations
12.
Archin, Nancie M., Manzoor Cheema, Daniel Parker, et al.. (2010). Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection. PLoS ONE. 5(2). e9390–e9390. 130 indexed citations
13.
Mens, Helene, Mary F. Kearney, Ann Wiegand, et al.. (2010). HIV-1 Continues To Replicate and Evolve in Patients with Natural Control of HIV Infection. Journal of Virology. 84(24). 12971–12981. 74 indexed citations
14.
Pereyra, Florencia, Sarah Palmer, Toshiyuki Miura, et al.. (2009). Persistent Low‐Level Viremia in HIV‐1 Elite Controllers and Relationship to Immunologic Parameters. The Journal of Infectious Diseases. 200(6). 984–990. 159 indexed citations
15.
Archin, Nancy M., Joseph J. Eron, Sarah Palmer, et al.. (2008). Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells. AIDS. 22(10). 1131–1135. 149 indexed citations
16.
Maldarelli, Frank, Sarah Palmer, Martin King, et al.. (2007). ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia. PLoS Pathogens. 3(4). e46–e46. 267 indexed citations
17.
Hogue, Ian B., Sarah Palmer, Cheryl Jennings, et al.. (2005). Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. The Lancet. 366(9485). 549–555. 409 indexed citations
18.
Palmer, Sarah, Ann Wiegand, Frank Maldarelli, et al.. (2003). New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma. Journal of Clinical Microbiology. 41(10). 4531–4536. 470 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Alireza Rabi Breakdown of academic impact, for papers by Delphine Engel Breakdown of academic impact, for papers by Geethanjali Dornadula Breakdown of academic impact, for papers by Anne Ellett Breakdown of academic impact, for papers by Jun Lai Breakdown of academic impact, for papers by Maarten Koot Breakdown of academic impact, for papers by Megan Mefford Breakdown of academic impact, for papers by Åsa Björndal Breakdown of academic impact, for papers by Silvia Ratto‐Kim Breakdown of academic impact, for papers by Ronald J. Plishka
Rankless by CCL
2026